Pharmaceuticals, Biotechnology and Life Sciences
NEW HAVEN, Conn., June 22, 2021 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company…
Broad multi-year agreement between Sorrento Therapeutics and U.S. Naval Medical Research Unit – No. 3 (NAMRU-3) headquartered in Sigonella, Italy…
– First selective MET inhibitor approval in China in this setting – – First regulatory approval for the oral, potent and selective…
KIELPIN, Poland, June 22, 2021 (GLOBE NEWSWIRE) — Celon Pharma today announced filing for approval to start a Phase II…
InMed invites individual and institutional investors, as well as advisors and analysts, to attend a real-time, interactive presentation on LifeSciencesInvestorForum.comVANCOUVER,…
STRATHROY, Ontario, June 21, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”)…
Selection of Premier Research as CRO Marks Significant Milestone Toward Initiation of Phase 3 Program of Simufilam in Alzheimer’s DiseaseAUSTIN,…
BELTSVILLE, Md., June 21, 2021 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company discovering and developing novel,…
DURHAM, N.C., June 21, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (the “Company” or “Novan”) (NASDAQ:NOVN) today announced the closing of…
PRINCETON, N.J., June 21, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on…